Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Rindopepimut |
Trade Name | |
Synonyms | CDX-110|PF-04948568 |
Drug Descriptions |
Rindopepimut (CDX-110) is a peptide vaccine that targets EGFRvIII, which may stimulate immune response against EGFRvIII-expressing cells (PMID: 32034072). |
DrugClasses | |
CAS Registry Number | 946156-74-7 |
NCIT ID | C69076 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bevacizumab + Rindopepimut | Bevacizumab Rindopepimut | 0 | 0 |
Rindopepimut | Rindopepimut | 0 | 0 |